AbbVie (ABBV) Q3 2023 Earnings Call Transcript

ABBV earnings call for the period ending September 30, 2023.

Related Keywords

China ,Japan ,Gary Nachman ,America Merrill Lynch ,Terence Flynn ,Gary Nachman Raymond James ,Raymond James ,Rick Gonzalez ,Alice Nettleton ,David Risinger ,Skyrizi Rinvoq ,Tervita Rinvoq ,Chris Schott ,Equita Europe ,Chris Shibutani Goldman Sachs ,Luisa Hector ,Geoff Meacham ,Chris Schott Jpmorgan ,Scott Renz ,Tom Hudson ,Luisa Hector Berenberg ,Steve Scala ,David Risinger Leerink ,Mohit Bansal ,Evan Seigerman ,Jeff Stewart ,Rob Michael ,Chris Shibutani ,Tim Anderson ,Liz Shea ,Terence Flynn Morgan Stanley ,Company Analyst ,Global Regulatory Affairs ,Goldman Sachs ,Wells Fargo ,Wolfe Research ,Allergan ,Alice Nettleton Wolfe Research Analyst ,Geoff Meacham Bank ,Morgan Stanley ,Carry Strom ,Ruple Sachar ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Chief Operating ,Vice President ,Chief Commercial ,Global Humira ,Botox Therapeutic ,Global Allergan ,Botox Cosmetic ,Skin Vive ,Chief Scientific ,Chief Financial ,Fargo Securities ,Skin Veeva ,Vamil Divan ,Reduction Act ,Capital Markets ,Global Regulatory ,Wells Fargo Securities ,Guggenheim Partners ,Berenberg Capital Markets ,